Results 271 to 280 of about 308,964 (330)

Change in body mass index and disease burden among people with obesity and multiple long‐term conditions

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Obesity is a risk factor for multiple long‐term conditions (MLTCs/multimorbidity). However, the impact of weight loss in people with MLTCs is unclear. We investigated the association between body mass index (BMI) change and the development of obesity‐related complications (ORCs), as well as clinical and economic outcomes in individuals ...
Kamlesh Khunti, Alex Mourer, Silvia Capucci, Lua Wilkinson, Klaus K. Andersen, Abd A. Tahrani, Camilla S. Morgen   +6 more
wiley   +1 more source

Long Segment Coarctation of the Abdominal Aorta in a 12-Year-Old Patient: A Case Report. [PDF]

Cureus
Nayak D, Bisoyi S.
europepmc   +1 more source

Antihypertensive medication is not associated with increased disease severity in atopic dermatitis in the TREATgermany registry

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Moritz M. Hollstein, Stephan Traidl, Thomas Werfel, Jochen Schmitt, the TREATgermany Study Group   +4 more
wiley   +1 more source

Association of metabolic obesity phenotypes with cognitive decline in the ELSA‐Brasil study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To investigate the association between metabolic obesity phenotypes and cognitive decline and evaluate the potential mediating role of C‐reactive protein (CRP). Methods Longitudinal cohort study using three waves (2008–2019) of the Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil).
Paulo Henrique Lazzaris Coelho, Natalia Gomes Gonçalves, Itamar S. Santos, Alessandra C. Goulart, Sandhi Maria Barreto, Luana Giatti, Paulo Caramelli, Paulo Andrade Lotufo, Isabela Martins Bensenor, Claudia Kimie Suemoto   +9 more
wiley   +1 more source

Impact of Antihypertensive Treatment Adherence on Premature Mortality over Seven Years: A Follow-Up Investigation. [PDF]

J Clin Med
Elehamer NMK, Merzah M, Saeed SN, Sándor J, Czifra Á.   +4 more
europepmc   +1 more source

Risk of acute pancreatitis with DPP‐4 inhibitors versus SGLT2 inhibitors in medication‐naïve individuals with diabetes: A target trial emulation

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims We investigated whether dipeptidyl peptidase‐4 inhibitor (DPP‐4i) use was associated with a higher risk of acute pancreatitis compared with sodium–glucose cotransporter 2 inhibitor (SGLT2i) use in antidiabetic medication‐naïve individuals.
Takashi Tatewaki, Akira Okada, Yuya Kimura, Hideo Yasunaga   +3 more
wiley   +1 more source

Association between prenatal exposure to antihypertensive medication and neurodevelopmental and educational outcomes in children. [PDF]

Sci Rep
Alkhalaf S, Singh S, Pell JP, Nelson SM, Mackay DF, Fleming M.   +5 more
europepmc   +1 more source

SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Randomized controlled trials on sodium‐glucose cotransporter 2 (SGLT2) inhibitors have yielded inconsistent findings regarding mortality benefits. It remains unclear whether, and in which subgroups, SGLT2 inhibitors confer survival benefits in older adults with diabetic kidney disease (DKD).
Tatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, Yuta Suzuki, Toshiyuki Ko, Kazuki Aoyama, Takashin Nakayama, Yuya Kimura, Katsuhiko Fujiu, Norifumi Takeda, Hiroyuki Morita, Takashi Yokoo, Koichi Node, Masaomi Nangaku, Norihiko Takeda, Hideo Yasunaga, Kaori Hayashi   +16 more
wiley   +1 more source

Exploring adherence to antihypertensive medication in Black African and Black Caribbean residents in South East London: a qualitative study. [PDF]

BJGP Open
Yogarajah N, Griffiths K, Bramham K, Baraniak A.   +3 more
europepmc   +1 more source